Literature DB >> 2897611

Loss of genes on the long arm of chromosome 22 in human meningiomas.

M Okazaki1, I Nishisho, H Tateishi, K Motomura, M Yamamoto, T Miki, T Hayakawa, S Takai, T Honjo, T Mori.   

Abstract

It has been proposed that loss of genes at specific chromosomal loci leads to tumorigenesis in some human tumors. This type of oncogenesis was first demonstrated in retinoblastoma and Wilms' tumor. Recently, it has been reported that acoustic neuroma, ductal breast tumor, and renal cell carcinoma may be caused by the same mechanism. Cytogenetic studies demonstrated that some meningiomas have monosomy of chromosome 22. In addition, human meningiomas are often associated with bilateral acoustic neuroma in which specific loss of alleles on chromosome 22 has been demonstrated. Then, we compared constitutional and tumor genotypes from 14 cases of sporadic human meningiomas, using four polymorphic DNA probes on chromosome 22 (SIS, D22S1, D22S9, IGLC). Loss of constitutional heterozygosity was found in three of 11 informative cases. Two of the three meningiomas maintained constitutional heterozygosity at the IGLC locus and another one showed no loss of heterozygosity at IGLC or D22S9. These results suggest that loss of genes on chromosome 22 caused by either a partial deletion or a mitotic recombination at a locus distal to D22S9 plays an important role in tumorigenesis of the human meningioma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897611

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  7 in total

1.  Identification of twelve new RFLP-markers on chromosome 22q11-qter.

Authors:  E Carlbom; N Sugawa; C Larsson; P J Scambler; J P Dumanski; V P Collins; M Nordenskjöld
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

2.  A system for assaying homologous recombination at the endogenous human thymidine kinase gene.

Authors:  M B Benjamin; H Potter; D W Yandell; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.

Authors:  G A Rouleau; B R Seizinger; W Wertelecki; J L Haines; D W Superneau; R L Martuza; J F Gusella
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

4.  Growth retardation and bilateral cataracts followed by anaplastic meningioma 23 years after high-dose cranial and whole-body irradiation for acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Alexei I Korenkov; Hans G Imhof; Sebastian Brandner; Ethan Taub; Pia U Huguenin; Michael R Gaab; Yasuhiro Yonekawa
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.

Authors:  S Khosla; V M Patel; I D Hay; D J Schaid; C S Grant; J A van Heerden; S N Thibodeau
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.

Authors:  R K Wolff; K A Frazer; R K Jackler; M J Lanser; L H Pitts; D R Cox
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

Review 7.  Molecular mechanisms of cancer.

Authors:  H P Koeffler; F McCormick; C Denny
Journal:  West J Med       Date:  1991-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.